Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ABT Abbott Laboratories
111.990+1.240+1.12%
Close
02/07 16:00 ET
111.9900.0000.00%
Pre Mkt Price 02/08 04:05 ET
High
112.410
Open
110.040
Turnover
379.63M
Low
109.880
Pre Close
110.750
Volume
3.40M
Pre-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Abbott Laboratories Stock Rises Tuesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Abbott Laboratories (ABT) rallied 1.12% to $111.99 Tuesday, on what proved to be an all-aro
Is It a Good Choice to Invest in Abbott Laboratories (ABT)?
Blair William & Co. IL Buys 24,534 Shares of Abbott Laboratories (NYSE:ABT)
Blair William & Co. IL increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.3% during the third quarter, according to the company in its most recent 13F filing with t
Abbott Laboratories (NYSE:ABT) Is SBB Research Group LLC's 8th Largest Position
SBB Research Group LLC reduced its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 7.4% in the third quarter, according to its most recent filing with the Securities & Exchange Commission
Abbott Laboratories Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Abbott Laboratories (ABT) sank 0.93% to $110.75 Monday, on what proved to be an all-around
California Public Employees Retirement System Has $485.22 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)
California Public Employees Retirement System raised its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 9.9% in the third quarter, according to its most recent Form 13F filing with the S
Extracorporeal Membrane Oxygenation (ECMO) Machine Market Report (2022 to 2030) - Xenious AG, Terumo Group, Getinge AB, Abbott Laboratories, and Nipro Medical Corporation
Newark, New Castle, USA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The global extracorporeal membrane oxygenation machine market is expected to clock US$ 452.7 million by 2030. The market is influenced by increased incidence
Mark Sheptoff Financial Planning LLC Sells 2,150 Shares of Abbott Laboratories (NYSE:ABT)
Mark Sheptoff Financial Planning LLC lowered its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 3.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission.
Abbott Laboratories Stock Falls Friday, Still Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Abbott Laboratories (ABT) dropped 0.41% to $111.79 Friday, on what proved to be an all-arou
Worldwide Cardiovascular Diagnostic & Monitoring Devices Industry to 2031 - Featuring Abbott Laboratories, Biotronik, Boston Scientific and GE Healthcare Among Others
Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Cardiovascular Diagnostic & Monitoring Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031" report has been added
Company Overview
More
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL.
CEO： Mr. Robert B. Ford
Market： NYSE
Listing Date： 01/01/1929
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet